
Strides Pharma Science Limited has informed the Exchange regarding a press release dated May 25, 2023, titled "Strides reports strong Q4FY23 results and lays the foundation for a promising FY24".
Filed with NSE ·

Strides Pharma Science Limited has informed the Exchange regarding a press release dated May 25, 2023, titled "Strides reports strong Q4FY23 results and lays the foundation for a promising FY24".
6ix hasn’t read this filing yet.
Strides Pharma Science Ltd on 6ix
Follow Strides Pharma Science into a list and get an email when it puts out news.
Follow Strides Pharma Science